SMS Pharmaceuticals Limited (NSE:SMSPHARMA)

SMS Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, SMS Pharmaceuticals had annual revenue of 8.95B INR with 14.37% growth. SMS Pharmaceuticals had revenue of 2.41B in the quarter ending March 31, 2026, a decrease of -3.09%.

• Revenue: 8.95B
• Revenue Growth: +14.37%
• P/S Ratio: 3.99
• Revenue / Employee: 6.09M
• Employees: 1,470
• Market Cap: 35.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	8.95B	1.12B	14.37%
Mar 31, 2025	7.83B	734.85M	10.36%
Mar 31, 2024	7.09B	1.87B	35.86%
Mar 31, 2023	5.22B	21.77M	0.42%
Mar 31, 2022	5.20B	-433.03M	-7.69%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 24, 2026

Data Sources Report a data error